Establishment of Genetic Basis for Neurological Disease by Genetic Screening

Plain-language summary

This study aims to identify the genetic basis of presumed hereditary neurological disease using a gene-chip screening kit (Genechip). It enrolls people aged 18 and older who have a presumed hereditary neurological disease. The trial is a non-phase study and is enrolling by invitation.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Enrolling by invitation

Sponsor

Chinese University of Hong Kong

Intervention

Genechip screening kit

Start date

11/16/2012

Estimated completion

12/31/2025

Countries

Hong Kong

Related genes

Locations

• Hong Kong, Hong Kong

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

1. Individuals at age 18 years or older who have presumed hereditary neurological disease.
2. Individuals or his/her guardian who can provide the informed consent.

Exclusion Criteria:

1. Individuals who are allergic to local anesthetics.
2. Individuals who have serious medical conditions that restrict their ability to tolerate skin biopsy.
3. Individuals who have history of bleeding diathesis or use of anticoagulant medications. Patients taking nonsteroidal anti-inflammatory agents will be asked to discontinue these medications 3 days prior to skin biopsy.